Prevalence of metabolic syndrome among 40- and 50-year-old inhabitants of Wroclaw, Poland

• Autorzy: Ilow R. , Regulska-Ilow B. , Rozanska D. , Kowalisko A. , Biernat J.
• Języki publikacji: EN

Abstrakty

EN

Introduction and objective. The metabolic syndrome (MetS) has been discussed for many years, but there is no doubt that those who have confirmed the presence of risk factors comprising the MetS had a higher risk of cardiovascular disease. The aim of this study was to evaluate the prevalence of MetS among 40- and 50-year-old (y.o.) inhabitants of Wroclaw, Poland. Materials and methods. The study group included Wroclaw inhabitants who were recruited between 2001-2004 into the Cardiovascular Disease Prevention Programme. The study group consisted of 18,583 participants (females: 40 y.o. – 5,248 and 50 y.o. – 5,329; males: 40 y.o. – 4,229 and 50 y.o. – 3,777). The MetS was defined by IDF/NHLBI/AHA (2009) criteria. Results. MetS was found in 12.7% of 40 y.o. and in 33.1% of 50 y.o. females, while in males, respectively, in 30.4% and 42.1%. Overall, MetS occurred in 28.5% of the study group. MetS occurred significantly more frequent among the older than the younger groups, both in females and males. MetS was found significantly more frequent among males than females from Wroclaw, in both 40- and in 50 y.o. participants. Among those females with MetS, the most frequently (more than 90% in both age groups) occurred excessive waist circumference (WC), followed by elevated blood pressure-BP (72.1% of 40 y.o., 86.8% of 50 y.o.). Excessive WC, elevated BP and triglycerides-TG was found in more than 80% of males aged 40 and with diagnosed MetS. Among the older group of males with MetS, the most frequently occurred elevated BP (90.4%), followed by excessive WC (87%) and elevated TG (78.5%). Conclusion. MetS was diagnosed more frequent in males than females of Wroclaw. Prevalence of MetS increased with age. The most significant impact on reducing the prevalence of MetS in the study group would be the lowering of BP and WC to recommended values.

• Wydawca: -
• Czasopismo: Annals of Agricultural and Environmental Medicine
• Rocznik: 2012
• Tom: 19
• Numer: 3
• Opis fizyczny: p.551-556,fig.,ref.

Twórcy

autor

Ilow R.

• Department of Food Science and Dietetics, Wroclaw Medical University, Wroclaw, Poland

autor

Regulska-Ilow B.

• Department of Dietetics, Wroclaw Medical University, Wroclaw, Poland

autor

Rozanska D.

• Department of Dietetics, Wroclaw Medical University, Wroclaw, Poland

autor

Kowalisko A.

• Cardiology Centre – Pro Corde, Wroclaw, Poland

autor

Biernat J.

• Department of Food Science and Dietetics, Wroclaw Medical University, Wroclaw, Poland

Bibliografia

• 1. Popkin BM, Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes. 2004; 28: S2-S9.
• 2. Shaw JE, Sicree RA, Zimmet PZ. Diabetes Atlas. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pr. 2010; 87: 4-14.
• 3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223.
• 4. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Geneva: World Health Organization 1999.
• 5. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999; 16: 442-443.
• 6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
• 7. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
• 8. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet 2005; 366: 1059-1062.
• 9. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;International Atherosclerosis Society; and International Associationfor the Study of Obesity. Circulation 2009; 120: 1640-1645.
• 10. Wyrzykowski B: Zespół metaboliczny w praktyce klinicznej. Vol. 1. Via Medica, Gdańsk 2010. p.137, 139-150 (in Polish).
• 11. Reaven GM. Insulin resistance, cardiovascular disease, and the metabolic syndrome. Diabetes Care. 2004; 27: 1011-1012.
• 12. Reaven GM. Just being alive is not good enough. Clin Chem. 2005; 51: 1354-1357.
• 13. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem. 2005; 51: 931-938.
• 14. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006; 83: 1237-1247.
• 15. Gale EAM. The myth of the metabolic syndrome. Diabetol. 2005; 48: 1679-1683.
• 16. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, et al. Can metabolic syndrome usefully predict cardiovasculardisease and diabetes? Outcome data from two prospective studies.Lancet 2008; 371: 1927-1935.
• 17. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal Joint statement from the American DiabetesAssociation and the European Association for the Study of Diabetes.Diabetes Care 2005; 28: 2289-2304.
• 18. Kahn R. Metabolic syndrome – what is the clinical usefulness? Lancet 2008; 371: 1892-1893.
• 19. Federspil G, Nisoli E, Vettor R. A critical reflection on the definition of metabolic syndrome. Pharmacol Res. 2006; 53: 449-456.
• 20. Grundy SM. The metabolic syndrome still lives. Clin Chem. 2005; 51: 1352-1357.
• 21. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008; 28: 629-636.
• 22. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk. A systematic review andmeta-analysis. J Am Coll Cardiol. 2010; 56: 1113-1132.
• 23. Guize L, Pannier B, Thomas F, Bean K, Jégo B, Benetos A. Recent advances in metabolic syndrome and cardiovascular disease. ArchCardiovasc Dis. 2008; 101: 577-583.
• 24. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006; 119: 812-819.
• 25. Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, et al. Comparison of four definitions of the metabolicsyndrome in a Greek (Mediterranean) population. Curr Med ResOpin. 2010; 26: 713-719.
• 26. Luksiene DI, Baceviciene M, Tamosiunas A, Reklaitiene R, Radisauskas R. Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population. Int JPublic Health. 2011; DOI: 10.1007/s00038-011-0244-x
• 27. Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jöckel K-H. Impact of 4 different definitions used for the assessment of theprevalence of the Metabolic Syndrome in primary healthcare: TheGerman Metabolic and Cardiovascular Risk Project (GEMCAS).Cardiovasc Diabetol. 2007; 6: 22, DOI: 10.1186/1475-2840-6-22.
• 28. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. DiabetesCare. 2005; 28: 2745-2749.
• 29. Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E, Chittleborough C, et al. Population comparison of two clinicalapproaches to the metabolic syndrome. Diabetes Care. 2005; 28: 2777-2779.
• 30. Wyrzykowski B, Zdrojewski T, Sygnowska E, Biela U, Drygas W, Tykarski A, et al. Epidemiologia zespołu metabolicznego w Polsce. Wyniki programu WOBASZ. (Epidemiology of metabolic syndromein Poland. Results of the WOBASZ program). Kardiol Pol. 2005; 63(6 Suppl. 4): S1-S4 (in Polish).
• 31. Janszky I, Vatten L, Romundstad P, Laugsand LE, Bjørngård JH, Mańczuk M, Zatoński WA. Metabolic syndrome in Poland – the PONS Study. Ann Agric Environ Med 2011; 18: 270-272.
• 32. Wyrzykowski B, Bandosz P, Zdrojewski T. Ocena częstości występowania zespołu metabolicznego w Polsce. (Prevalence of metabolic syndrome in Poland) Kardioprofil. 2006; 4: 3-11 (in Polish).

Uwagi

rekord w opracowaniu